Diagnostic utility of neutrophil CD64 as a marker of early-onset sepsis in very low birth weight neonates by Meena, Kessh Ram et al.
Vol 5 | Issue 5 | May 2018 Indian J Child Health 345
Original Article
Diagnostic utility of neutrophil CD64 as a marker of early-onset sepsis in very 
low birth weight neonates
Kessh Ram Meena1, Priyanka Tiwari2, Pradeep Debata3
1Associate Professor, 2Senior Resident, 3Professor, Department of Pediatric Medicine, VMMC and Safdarjang Hospital, New Delhi, India
Correspondence to: Dr. Kessh Ram Meena, Associate Professor, Department of Pediatric Medicine, VMMC and Safdarjang Hospital, 
New Delhi - 110 029, India. E-mail: krkrmeena@gmail.com
Received – 16 April 2018 Initial Review – 16 May 2018 Published Online – 22 June 2018
In neonates, sepsis continues to be a major cause of morbidity and mortality [1]. As per the national neonatal-perinatal database (2002–2003), the incidence of neonatal sepsis is 
30/1000 live births [2]. The incidence is higher among very low 
birth weight (VLBW) infants. Early recognition and diagnosis of 
neonatal sepsis is difficult because of its variable and non-specific 
clinical presentation. It is extremely important to make an early 
diagnosis of sepsis because prompt institution of antimicrobial 
therapy improves outcomes and delayed or missed treatment can 
have serious consequences. Attempts have been made to seek an 
ideal early marker of neonatal sepsis. Physiologic parameters, 
hematologic indices, and cytokine profile have been identifying 
neonates with sepsis [3-5].
The complete blood count and leukocyte differential assays 
have relatively poor specificity for diagnosing sepsis. The band 
cells and leftward shift of myeloid immaturity measurements 
may improve diagnostic yield, but their subjective measurement 
is problematic. The gold standard for the diagnosis of neonatal 
sepsis is blood culture, but it has some limitations. There may 
be delay in the final culture results for 48–72 h. This results in 
admission to a NICU and separation from parents as well as 
increased cost to the health-care system. Genuine bacteremia 
may remain undetected in a significant proportion of infected 
cases [6]. Therefore, the need persists for improved diagnostic 
indicators of neonatal sepsis.
The CD64 is expressed at very low concentration on surface of 
neutrophils in the absence of bacterial infection. During bacterial 
sepsis, the CD64 expression increases [6]. CD64 expression on 
neutrophil is induced by immunoglobulin G (IgG), interferon 
gamma, or granulocyte colony-stimulating factors [7]. Following 
contact with an antigen, the antigen-IgG complex binds to CD64. 
This process further increases CD64 expression. Available 
literature shows that neutrophil CD64 seems to be a highly 
sensitive and specific biomarker for sepsis. However, nearly, all 
studies included relatively small patient numbers [8]. There is an 
enormous variation in criteria for selecting patients, differences in 
the definition of sepsis, as well as poorly standardized analytical 
methodology. Moreover, there is a paucity of data in this age 
group and very few studies have been conducted on this topic, so 
far none of which are carried out in India.
The present study is an effort to fulfill the gap in the existing 
literature. This study was planned to evaluate the efficacy of 
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neutrophil CD64 expression for diagnosis of early-onset sepsis 
(EOS) in VLBW neonates. We also planned to compare neutrophil 
CD64 marker with other currently used infection markers 
including total leukocyte count (TLC), absolute neutrophil count 
(ANC), C-reactive protein (CRP), platelet counts, and blood 
culture.
METHODS
This prospective observational study was conducted at a tertiary 
care teaching institute from Delhi, India, from January 2015 
to December 2015. The study was approved by the ethical 
committee. Written informed consent was obtained from parents 
or legal guardian before enrollment. Study population was 
VLBW neonates admitted in neonatal division of the department 
of pediatrics. Inclusion criteria were neonates with birth weight 
<1500 g and postnatal age ≤72 h, admitted to NICU with signs 
and symptoms of sepsis such as hyperthermia or hypothermia, 
tachycardia or bradycardia, CRT >3 s, severe chest indrawing, 
abdominal distention, bulging fontanel, decreased movements, 
feeding difficulty, convulsion, umbilical sepsis, and multiple skin 
pustules and born to mothers with or without risk factor for sepsis. 
Neonates with chromosomal or gross congenital abnormalities 
were excluded from the study.
Cases were all VLBW neonates with culture-positive sepsis or 
clinical sepsis as per the CDC definition. This included neonates 
having all of the following criteria: Existence of predisposing 
risk factors (maternal fever within 7 days before delivery or foul-
smelling liquor or prolonged rupture of membranes [>18 h]) or 
radiological evidence of pneumonia or culture from any body 
fluid comes positive or positive sepsis screen. Controls were all 
VLBW neonates initially suspected of having sepsis but have 
negative blood culture and have negative sepsis screen. Assuming 
dropout rate of 10% and with alpha=0.05 and p=80%, the study 
was carried out on 151 cases and equal number of controls.
For all these neonates, venous blood sample was drawn under 
aseptic precaution for blood culture, sepsis screen, and CD64 
within first 24 h of birth. A second blood sample was obtained 
between 25 and 72 h after birth from those neonates who required 
additional laboratory tests. 10 ml of whole blood was incubated 
with fluorescein isothiocyanate (FITC) conjugated monoclonal 
antibody against CD64 (anti-CD64) for 10 minutes. This was 
followed by red cell lysis by adding lysis reagent. Later, flow 
cytometry was done using Guava Easycyte flow cytometer 
to collect log FITC fluorescence, log right angle side scatter, 
and forward scatter on a minimum of 50,000 leukocytes. Data 
analysis was performed using light scatter gating to define the 
neutrophil population, and CD64 positivity was quantified as 
mean equivalent to soluble fluorescence units using the Guava 
Easycyte software with a correction for non-specific antibody 
binding by subtracting values for the isotype control. Interassay 
standardization and CD64 quantification were performed using 
FITC calibration beads.
Categorical variables were presented in number and percentage, 
and continuous variables were presented as mean ± standard 
deviation. Normality of data was tested by Kolmogorov–Smirnov 
test. If the normality was rejected, then non-parametric test was 
used. Quantitative variables were compared using unpaired 
t-test/Mann–Whitney test. Qualitative variables were correlated 
using Chi-square test/Fisher’s exact test. Receiver operating 
characteristic (ROC) curve was used to find out cutoff point of 
CD64. Diagnostic test was used to find out sensitivity, specificity, 
negative predictive value (NPV), and positive predictive value 
(PPV) of various parameters for the prediction of sepsis. p<0.05 
was considered statistically significant. The data were entered 
into MS Excel spreadsheet, and analysis was done using SPSS 
version 21.
RESULTS
During the study period, 302 VLBW neonates satisfied the 
inclusion criteria and were included in the study. A total of 413 
neutrophil CD64 detections (302 and 111 detections obtained 
at 0–24 h and at 25–72 h after birth, respectively) were done. 
Among these 302 VLBW neonates, 151 were belonged to sepsis 
group (30 - culture proven and 121 - culture negative sepsis) and 
151 were belonged to the control group. The demographic data 
of two groups are summarized in Table 1. Cases were of lesser 
gestational age than those of control (p<0.002). Birth weight was 
also significantly lower in cases than control (p<0.003). Maternal 
risk factors for sepsis were higher among cases than control 
(p<0.011). However, there was no difference in sex ratio among 
cases and controls.
The level of hematological markers for sepsis and neutrophil 
CD64 is summarized in Table 2. The level of CD64 was higher 
among cases (p<0.0001), TLC and ANC were significantly lower 
in cases (p<0.0001), while I/T ratio and CRP were higher in cases 
in comparison to control (p<0.0001). There was no significant 
Table 1: Demographic profile and maternal risk factors for sepsis
Variables Cases (n=151) Controls (n=151) p
Gestational age in 
weeks (mean±SD)
31.82±2.52 32.75±1.92 0.002
Birth weight in 
grams (mean±SD)
1171.62±161.5 1235.3±136.03 0.003
Sex (Male: female) 76:75 77:74 0.908
Maternal risk factors 
for sepsis (present)
78 (51.66%) 56 (37.09%) 0.011
SD: Standard deviation
Table 2: Distribution profile of neutrophil CD64 expression in 
cases and controls
Variable Study group p
Cases, n (%) Controls, n (%)
CD64 (0–24 h), (n=302)
<2.2 9 (5.96) 151 (100.00) <0.0001
>2.2 142 (94.04) 0 (0.00)
CD64 (25–72 h), (n=111)
<3.2 0 (0.00) 46 (41.44) <0.0001
>3.2 64 (100.00) 1 (2.13)
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Table 3: Comparison of neutrophil CD64 expression with other currently used sepsis markers in the study group
Variable Number Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUC
CD64 (0–24 h) (>2.2) 302 94.04 100.00 100.00 94.37 0.970
CD64 (25–72 h) (>3.2) 111 100.00 97.87 98.46 100.00 0.989
TLC (<5000) 302 68.87 87.42 84.55 73.74 0.781
ANC (<1500) 302 55.63 100.00 100.00 69.27 0.778
I: T (>0.2) 302 49.01 100.00 100.00 66.23 0.745
Platelet count (<1 Lac) 302 11.26 90.07 53.13 50.37 0.507
AUC: Area under curve
Table 4: Sensitivity, specificity, PPV, and NPV and AUC for CD64 expression at 0–24 h and 25–72 h in combination with other parameters 
of sepsis screen
Variable Sensitivity (%) Specificity (%) PPV (%) NPV (%) AUC
CD64 (0–24 h) and TLC 64.90 100.00 100.00 74.02 0.825
CD64 (0–24 h) and I: T ratio 45.03 100.00 100.00 64.53 0.725
CD64 (0–24 h) and ANC 51.66 100.00 100.00 67.41 0.758
CD64 (0–24 h) and platelet count 11.26 100.00 100.00 52.98 0.556
CD64 (0–24 h) and blood culture 19.87 100.00 100.00 55.51 0.599
CD64 (25–72 h) and TLC 64.06 100.00 100.00 67.14 0.820
CD64 (25–72 h) and I: T ratio 51.56 100.00 100.00 60.26 0.758
CD64 (25–72 h) and ANC 46.88 100.00 100.00 58.02 0.734
CD64 (25–72 h) and platelet count 6.25 100.00 100.00 43.93 0.531
CD64 (25–72 h) and blood culture 64.06 100.00 100.00 67.14 0.820
AUC: Area under curve, PPV: Positive predictive value, NPV: Negative predictive value, TLC: Total leukocyte count, ANC: Absolute neutrophil count
Figure 1: Receiver operating characteristic curve depicting the area 
under curve for neutrophil CD64 expression and other currently 
used sepsis markers
difference in platelet count in cases and control. For all parameters, 
ROC curve was constructed (Fig. 1). The highest area under curve 
(AUC) was observed using neutrophil CD64 followed by TLC. 
The neutrophil CD64 has AUC of 0.970 and 0.989 at 24 h and 
25–72 h of age, respectively (Table 3). Using a cutoff value of >2.2, 
the neutrophil CD64 yield a sensitivity, specificity, PPV, and NPV 
of 94.04%, 100%, 100%, and 94.37%, respectively. Neutrophil 
CD64 was followed by TLC, ANC, and I/T ratio. Cutoff value 
for neutrophil CD64 >3.2 at 25–72 h of age yielded sensitivity, 
specificity, PPV, and NPV of 100%, 97.87%, 98.46%, and 100%, 
respectively. It was observed that CD64 expression at 0–24 h of 
age had greater sensitivity, specificity, PPV, NPV, and AUC in 
comparison to CD64 expression at 25–72 h of age (Table 3).
The combination of CD64 expression (cutoff >2.2 at 24 h of 
age) with the predefined TLC criteria (<5000) yielded the highest 
sensitivity of 64.90%, the highest NPV of 74.02%, and also 
the highest AUC of 0.825 (Table 4). Similarly, the combination 
Table 5: Distribution of hematological parameters and neutrophil 
CD64 expression in the sepsis group with respect to blood culture
Variables Blood culture 
negative n=121 (%)
Blood culture 
positive n=30 (%)
p
TLC
>5000 34 (28.10) 13 (43.33) 0.107
<5000 87 (71.90) 17 (56.67)
ANC
<1500 49 (40.50) 18 (60.00) 0.054
<1500 72 (59.50) 12 (40.00)
I: T ratio
<0.2 64 (52.89) 13 (43.33) 0.348
>0.2 57 (47.11) 17 (56.67)
CRP
Negative 44 (36.36) 13 (43.33) 0.481
Positive 77 (63.64) 17 (56.67)
CD64 (0–24 h)
<2.2 9 (7.44) 0 (0.00) 0.206
>2.2 112 (92.56) 30 (100.00)
CD64 (25–72 h) n=34 (%) n=30 (%)
>3.2 34 (100.00) 30 (100.00)
ANC: Absolute neutrophil count, TLC: Total leukocyte count, CRP: C-reactive 
protein 
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of CD64 expression (cutoff >3.2 at 25–72 h of age) with TLC 
yielded sensitivity of 64.06%. NPV 67.14% and AUC of 0.820 
which was highest when compared with combination with other 
hematological parameters. The sensitivity, PPV, and NPV were 
not calculated for the combination of multiple hematological 
markers because the basis for defining sepsis in this study was 
>2 positive hematological indices; this prior definition would 
produce a positive bias toward higher predictive value. Therefore, 
only single variable was examined.
There was no statistically significant difference in distribution 
of sepsis parameter (TLC, CRP, ANC, and I/T ratio) and neutrophil 
CD64 expression both at 0–24 h and 25–72 h of age in both blood 
culture-positive and negative group (Table 5). On comparison 
between CD64 expressions at 0–24 h and at 25–72 h of age in the 
sepsis group, it was observed that CD64 expression at 0–24 h of 
age had greater sensitivity, specificity, PPV, NPV, and AUC than 
the CD64 expression at 25–72 h of age (Table 6 and Fig. 2).
DISCUSSION
In our study, we found that the expression of neutrophil CD64 was 
significantly increased in the sepsis group as compared to control 
(p<0.001). The results in our study were found to be comparable 
to the results of previous studies. Soni et al. [9] have reported 
increased expression of neutrophil CD64 in neonates with sepsis. 
They found that the monocyte/neutrophil CD64 ratio was a highly 
sensitive marker of culture-positive neonatal sepsis. Ng et al. [10] 
and Livaditi et al. [11] have also observed increased expression 
of neutrophil CD64 in both early- and late-onset neonatal sepsis 
in VLBW infants. Espinosa et al. [12] also demonstrated similar 
results.
In the present study, an increasing level of neutrophil CD64 
expression was observed from birth to 72 h after birth. The 
highest performance was obtained from 0 to 24 h after birth. 
These findings are similar to study by Ng et al. [13]. Altogether, 
the results of these studies suggest that a single detection of 
neutrophil CD64 expression could be reliable diagnostic marker 
of EOS when performed 0–24 h after birth. This would be 
particularly important in VLBW neonates where EOS is a com 
mon condition and if infection could be ruled out at birth, it could 
significantly affect the therapeutic decision with respect to the 
antibiotic treatment. Given the high NPV of neutrophil CD64 
expression 24 h after the onset of EOS (100.00%), it has the 
strong potential to influence the initiation, early termination, and 
duration of treatment by antibiotics.
In the present study, comparison was done between the 
currently used hematological parameters for the diagnosis of 
neonatal sepsis and neutrophil CD64 expression in terms of 
diagnostic tools of evaluation. Neutrophil CD64 expression 
was found to have highest AUC with the highest sensitivity, 
specificity, and NPV. This is in agreement with the results 
demonstrated by Espinosa et al. [12], Livaditi et al. [11], and 
Table 6: ROC characteristics for CD64 expression in blood culture-positive cases
Variables AUC Standard error 95% CI p value Associated criterion Sensitivity (%) Specificity (%)
CD64 (0–24 h) 0.798072 0.0362 0.725122–0.858955 <0.0001 >3.2 93.33 65.29
CD64 (25–72 h) 0.662255 0.0682 0.533166–0.775776 0.0174 >4.4 86.67 44.12
AUC: Area under curve, CI: Confidence interval, ROC: Receiver operating characteristic
Figure 2: (a) Receiver operating characteristic (ROC) curves for CD64 expression at 0–24 h of age when plotted against blood culture. (b) ROC 
curves for CD64 expression 25–72 h of age when plotted against blood culture
a b
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Bhandari V et al. [14]. An attempt was made in the present study 
to see the diagnostic efficacy when combining neutrophil CD64 
with currently used hematological markers used for the neonatal 
sepsis. It was found that neutrophil CD64 in combination with 
predefined TLC criteria (<5000) yielded the highest sensitivity, 
NPV, and AUC in comparison with other combinations. 
Combination of multiple hematological indices was not used 
because that will result in positive bias toward higher predictive 
values.
In our study, culture-positive sepsis was found in 30 
neonates with sensitivity, specificity, PPV, and NPV of 19.87%, 
100%, 100%, and 55.51%, respectively. Using the ROC curve 
analysis against blood culture, cutoff values for neutrophil 
CD64 expression were determined as >3.2 at 0–24 h of age 
and >4.4 at 25–72 h of age. With these cutoffs, the efficacy 
of neutrophil CD64 expression was determined in culture-
positive group, and CD64 expression at 0–24 h of age had 
better sensitivity and NPV (93.33% and 97.53%, respectively) 
with AUC of 0.793 as compared to CD64 expression at 25–72 
h of age. Previous studies have also reported the similar 
findings [9,14-18]. Thus, it may be concluded that early 
postnatal assessment of the neutrophil CD64 expression 
showed a good performance in predicting EOS and was the 
most diagnostic measure of sepsis.
CONCLUSION
Neutrophil CD64 can be incorporated as a very useful diagnostic 
marker for EOS in neonates. Since we got the high NPV for CD64 
expression, it has strong potential to influence the initiation, early 
termination, and duration of antibiotic therapy.
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